Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-01-04 @ 4:21 AM
Study NCT ID:
NCT02782403
Status:
TERMINATED
Last Update Posted:
2020-11-19
First Post:
2016-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-11
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-20
First Submit QC Date:
None
Study First Post Date:
2016-05-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-17
Last Update Post Date:
2020-11-19
Last Update Post Date Type:
ACTUAL